Hosted on MSN1mon
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugsNovo CEO Lars Fruergaard Jorgensen sees Wegovy supply improving this year, and brushed off fears of the company falling behind Eli Lilly & Co. Details about its next-generation weight loss drugs ...
Novo Nordisk (NVO), the company behind popular diabetes and weight loss medications Ozempic and Wegovy, warned that President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results